Maravai Lifesciences Holdings (MRVI) Cash from Investing Activities Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -114.28% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 826.39% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -674.01% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 743.11 Mn | 734.71 Mn | 33.70 Mn | 80.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.82% |
| Dec 31, 2025 | 57.13% |
| Sep 30, 2025 | 67.34% |
| Jun 30, 2025 | 47.65% |
| Mar 31, 2025 | -444.98% |
| Dec 31, 2024 | 61.78% |
| Sep 30, 2024 | 42.27% |
| Jun 30, 2024 | 74.41% |
| Mar 31, 2024 | 93.91% |
| Dec 31, 2023 | 30.33% |
| Sep 30, 2023 | -165.44% |
| Jun 30, 2023 | -1,354.36% |
| Mar 31, 2023 | 71.14% |
| Dec 31, 2022 | -227.44% |
| Sep 30, 2022 | -104.93% |
| Jun 30, 2022 | 63.36% |
| Mar 31, 2022 | -8,577.59% |
| Dec 31, 2021 | 36.08% |
| Sep 30, 2021 | 1,275.58% |
| Jun 30, 2021 | -48.19% |